Bougainville Copper Stock
Price
Target price
€0.12
€0.12
-2.350%
-0.003
-2.350%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bougainville Copper Stock
A loss of -2.350% shows a downward development for Bougainville Copper.
Pros and Cons of Bougainville Copper in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bougainville Copper vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bougainville Copper | -2.350% | 0.000% | -2.672% | -66.270% | -70.890% | -44.079% | -53.125% |
| Alkane Resources Ltd. | 4.140% | 5.556% | -3.647% | 106.220% | 7.025% | 99.410% | 18.252% |
| Northern Minerals Ltd. | 1.200% | 0.602% | 0.602% | -11.170% | -1.765% | -19.712% | -35.019% |
| Talisman Mining Ltd. | 0.000% | 2.299% | 11.250% | -40.667% | -36.879% | -41.060% | -62.917% |
News
Arvinas Q2 Earnings Call Highlights
Key Points
- Interested in Arvinas, Inc.? Here are five stocks we like better.
- Arvinas is shifting resources to early-stage oncology and neurology programs after the FDA approved VEPPANU, the
